Skip to main content
2023 Midyear Clinical Meeting & Exhibition Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Certfified Pharmacy Executive Leader (CPEL)
Certfified Pharmacy Executive Leader (CPEL)
Integrated Informatics Institute
Integrated Informatics Institute
Back
Handout

Midday Symposia

Optimizing PARP Inhibitor Outcomes in Cancer Therapy: Focus on Biomarkers of Homologous Recombination Repair (Live Webinar)

Monday, December 4, 2023
11:30 AM – 1:00 PM  
Location: ACC North, Room 157, 100 Level
This interprofessional educational activity will review the science of homologous recombination deficiency and how it contributes to the development of cancer. Approved and expanded indications for the PARP inhibitors will be explained, including evidence for their use based on biomarkers, efficacy, and safety data.

Supported by educational grants from AstraZeneca and Merck. Contact: ASHP Advantage; elearning@ashp.org; CE Provider: American Society of Health-System Pharmacists.

More Information: www.ashp.org/products-and-services/ashp-advantage/ashp-advantage-programming/parp

    Faculty Member(s)

  • Jeannie Chern, MD, ScM

    Associate Member, Gynecologic Oncologist – H. Lee Moffitt Cancer Center
    Associate Professor, Gynecologic Oncologist – University of South Florida Morsani College of Medicine

  • Christine M. Walko, PharmD, BCOP, FCCP

    Senior Member, Department of Pathology, Precision Medicine Team Lead
    Moffitt Cancer Center